Pure Global

Microcurrent Stimulation for Dry Age-related Macular Degeneration - Trial NCT04511936

Access comprehensive clinical trial information for NCT04511936 through Pure Global AI's free database. This phase not specified trial is sponsored by i-Lumen Scientific, Inc. and is currently Withdrawn. The study focuses on Dry Age-related Macular Degeneration. Target enrollment is 0 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT04511936
Withdrawn
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT04511936
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Microcurrent Stimulation for Dry Age-related Macular Degeneration
Microcurrent Stimulation Therapy for Dry Age-related Macular Degeneration (i-SIGHT): a Multicenter, Randomized, Double-masked, Clinical Device Trial

Study Focus

i-Lumen AMD

Interventional

device

Sponsor & Location

i-Lumen Scientific, Inc.

Timeline & Enrollment

N/A

Mar 01, 2021

Jan 31, 2023

0 participants

Primary Outcome

Mean change from baseline in best-corrected distance visual acuity (CDVA) at one month timepoint.

Summary

Evaluate the safety and efficacy of microcurrent stimulation therapy for patients with dry
 age-related macular degeneration.

ICD-10 Classifications

Peripheral retinal degeneration
Corneal degeneration
Hereditary retinal dystrophy
Optic atrophy in diseases classified elsewhere
Disorders of choroid and retina

Data Source

ClinicalTrials.gov

NCT04511936

Device Trial